Redmile Group, LLC Teva Pharmaceutical Industries LTD Transaction History

Redmile Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $25.6 Million - $49.5 Million	-3,147,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $20.5 Million - $26.4 Million	1,318,100 Added 72.07%	3,147,000 $49.3 Million
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $26.7 Million - $43.6 Million	1,828,900 New	1,828,900 $28.2 Million

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.